Trends in Antiviral Drug Development

Trends in Antiviral Drug Development, presented by industry professionals with extensive experience in discovering new drugs and therapies, provides an in-depth look at successful antiviral compounds and treatments currently on the market or in clinical trials. Organized by virus target tissue, the book aligns with contemporary strategies in tissue-targeted therapeutics and highlights emerging trends such as long-acting drugs. It offers a clear view of the current and future state of antiviral drug development across a wide spectrum of viral infections.

Key Features:

• Covers novel drugs against herpes viruses and breakthrough therapies that cured HCV
• Explores siRNA therapeutics and emerging candidates for HBV cure
• Discusses drugs targeting viral entry, including HIV attachment, co-receptor binding, and fusion
• Reviews novel therapeutics for tropical diseases such as dengue fever and monkeypox
• Highlights current trends in long-acting and tissue-targeted antiviral therapies
• Essential resource for medicinal chemists, pharmaceutical chemists, virologists, and professionals in antiviral drug research